510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K981485Substantially Equivalent

Hybrid Capture II Gc-Id

Qiagen, Beltsville MD / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K981485 is the FDA 510(k) clearance record for HYBRID CAPTURE II GC-ID, a class II device, cleared for Digene Corp. on under FDA product code LSL (Dna-Reagents, Neisseria). FDA records list 26 510(k) clearances for QIAGEN, from to . As of , FDA records show no recalls naming K981485.

Clearance record

Decision date
Received
(584 days to decision)
Product code
LSL Dna-Reagents, Neisseria
Regulation
21 CFR 866.3390
Device class
Class II
Review panel
Microbiology
Applicant
Digene Corp. 9000 Virginia Manor Rd.,, Beltsville MD
510(k) summary
Summary
Third party review
No

Clearances, product code LSL

Trailing 12 months

FDA records hold no clearances under product code LSL in the trailing twelve months.

FDA records show no clearances under product code LSL in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LSL, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260